Format

Send to:

Choose Destination
See comment in PubMed Commons below
Lancet Neurol. 2008 Apr;7(4):327-40. doi: 10.1016/S1474-4422(08)70060-7.

Paraneoplastic syndromes of the CNS.

Author information

  • 1Division of Neuro-oncology, Department of Neurology, University of Pennsylvania, Philadelphia 19104, USA. josep.dalmau@uphs.upenn.edu

Abstract

Major advances in the management of paraneoplastic neurologic disorders (PND) include the detection of new antineuronal antibodies, the improved characterisation of known syndromes, the discovery of new syndromes, and the use of CT and PET to reveal the associated tumours at an early stage. In addition, the definition of useful clinical criteria has facilitated the early recognition and treatment of these disorders. In this article, we review some classic concepts about PND and recent clinical and immunological developments, focusing on paraneoplastic cerebellar degeneration, opsoclonus-myoclonus, and encephalitides affecting the limbic system.

PMID:
18339348
[PubMed - indexed for MEDLINE]
PMCID:
PMC2367117
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk